1. A potential idiotipic vaccine for the treatment of atherosclerosis based on a chimeric mouse/human anti-sulfated glycosaminoglycans antibody. Issue 1 (July 2015) Authors: Soto, Y.; Acosta, E.; Delgado-Roche, L.; Pérez, A.; Mesa, N.; Alfonso, Y.; Batlle, F.; Bécquer, M.A.; Griñán, T.; Brito, V.; Sarduy, R.; Zayas, F.; Vázquez, A.M. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A potential idiotipic vaccine for the treatment of atherosclerosis based on a chimeric mouse/human anti-sulfated glycosaminoglycans antibody. Issue 1 (July 2015) Authors: Soto, Y.; Acosta, E.; Delgado-Roche, L.; Pérez, A.; Mesa, N.; Alfonso, Y.; Batlle, F.; Bécquer, M.A.; Griñán, T.; Brito, V.; Sarduy, R.; Zayas, F.; Vázquez, A.M. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The treatment with an anti-glycosaminoglycan antibody reduces aortic oxidative stress in a rabbit model of atherosclerosis. (April 2013) Authors: Delgado-Roche, L.; Acosta, E.; Soto, Y.; Hernández-Matos, Y.; Olivera, A.; Fernández-Sánchez, E.; Vázquez, A. M. Journal: Free radical research Issue: Volume 47:Number 4(2013:Apr.) Page Start: 309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗